References
- Yu S Y, Qi R, Zhao H. Losartan reverses glomerular podocytes injury induced by AngII via stabilizing the expression of GLUT1. Mol Biol Rep. 2013;40(11):6295–6301
- Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature. 2003;425:577–584
- Faulds D, Goa KL, Benfield P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993;45:953–1040
- Shehata M, Cope GH, Johnson TS. Cyclosporine enhances the expression of TGF-bold beta in the juxtaglomerular cells of the rat kidney. Kidney Int. 1995;48:1487–1496
- Huse M, Chen YG, Massagué J. Crystal structure of the cytoplasmic domain of the type I TGF β receptor in complex with FKBP12. Cell. 1999;96:425–436
- Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753–791
- Piek E, Westermark U, Kastemar M. Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1. Int J Cancer. 1999;80:756–763
- Takakura K, Tahara A, Sanagi M. Antifibrotic effects of pirfenidone in rat proximal tubular epithelial cells[J]. Renal Fail. 2012;34(10):1309–1316
- Saglam F, Cavdar Z, Sarioglu S. Pioglitazone reduces peritoneal fibrosis via inhibition of TGF-β, MMP-2, and MMP-9 in a model of encapsulating peritoneal sclerosis. Renal Fail. 2012;34(1):95–102
- Zhang Y, Huang P, Jiang T. Role of aldose reductase in TGF-β1-induced fibronectin synthesis in human mesangial cells. Mol Biol Rep. 2010;37:2735–2742
- Firemann S, Feuring E, Padberg W. Improvement of nephrotoxicity, hypertension, and lipid metabolism after version of kidney transplant recipient from cyclosporine to tacrolimus. Transplant Proc. 1998;30:1240–1242
- Ikedo H, Tamaki K, Ueda S. Smad protein and TGF-β signaling in vascular smooth muscle cells. Int J Mol Med. 2003;11:645–650
- Schnaper HW, Hayashida T, Hubchak SC. TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol. 2003;284:F243–F252
- Buranakarl C, Kitjtawonrat A, Pondeenana S. Comparison of dipyridamole and fosinopril on renal progression in nephrectomized rats. Nephrology (Carlton). 2003;8:80–91
- Lan HY. Tubular epithelial-myofibroblast transdifferentia-tionmechanisms in proximal tubule cells. Curr Opin Nephro Hypertens. 2003;12:25–29
- Coimbra TM, Janssen U, Grone HJ. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 2000;57:167–182
- Aramburu J, Heitman J, Crabtree GR. Calcineurin: a central controller of signalling in eukaryotes. EMBO Rep. 2004;5:343–348
- Yu SY, Qi R. Role of bad in podocyte apoptosis induced by puromycin aminonucleoside. Transplant Proc. 2013;45:569–573
- Murphy GJ, Waller JR, Sandford RS. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. Br J Surg. 2003;90:680–686
- Ji SM, Li LS, Sha GZ. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy. Transplant Proc. 2007;39:1402–1405